Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. BJ
8. OSIS
9. HD
10. SFNC

Go back to Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.96 --0 (-0%)
Previous Close $51.96    52 Week High $45.58 
Open $51.96    52 Week Low $37.82 
Day High $51.96    P/E N/A 
Day Low $51.96    EPS $0.00 
Volume 113,871       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.96 --0 (-0%)
Previous Close $51.96    52 Week High $45.58 
Open $51.96    52 Week Low $37.82 
Day High $51.96    P/E N/A 
Day Low $51.96    EPS $0.00 
Volume 113,871